Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-14
2011-06-14
Spivack, Phyllis G. (Department: 1629)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07960429
ABSTRACT:
The present invention concerns methods useful in treating a subject having diarrhea-predominant IBS (IBS-D) by administering N methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamide and/or a pharmaceutically acceptable salt thereof to the subject.
REFERENCES:
patent: 4192883 (1980-03-01), Cousse
patent: 4663343 (1987-05-01), Horwell et al.
patent: 4760069 (1988-07-01), Rzeszotarski et al.
patent: 4806547 (1989-02-01), Giardina et al.
patent: 4889860 (1989-12-01), Rzeszotarski et al.
patent: 5091392 (1992-02-01), Raddatz et al.
patent: 5232266 (1993-08-01), Gottschlich et al.
patent: 5232978 (1993-08-01), Gottschlich et al.
patent: 5389686 (1995-02-01), Diop et al.
patent: 5532266 (1996-07-01), Gottschlich et al.
patent: 5585500 (1996-12-01), Drauz et al.
patent: 5776972 (1998-07-01), Barber et al.
patent: 5977161 (1999-11-01), Barber et al.
patent: 6060504 (2000-05-01), Stein et al.
patent: 6194454 (2001-02-01), Dow
patent: 6329403 (2001-12-01), Odaka et al.
patent: 6344566 (2002-02-01), Bathe et al.
patent: 6562363 (2003-05-01), Mantelle et al.
patent: 6569449 (2003-05-01), Swaan et al.
patent: 7164021 (2007-01-01), Welsh et al.
patent: 7563899 (2009-07-01), Boyd et al.
patent: 2001/0051181 (2001-12-01), Van Osdol et al.
patent: 2002/0025948 (2002-02-01), Banks et al.
patent: 2003/0036546 (2003-02-01), Clemens
patent: 2004/0157913 (2004-08-01), Jacob et al.
patent: 2004/0266806 (2004-12-01), Sanghvi et al.
patent: 2005/0004155 (2005-01-01), Boyd et al.
patent: 2005/0176746 (2005-08-01), Weber et al.
patent: 2006/0122255 (2006-06-01), Wiesner et al.
patent: 2007/0010450 (2007-01-01), Currie et al.
patent: 2006413 (1990-06-01), None
patent: 2054648 (1992-05-01), None
patent: 1081631 (2002-03-01), None
patent: 195 23 502 (1997-01-01), None
patent: 198 49 650 (2000-05-01), None
patent: 0330467 (1989-02-01), None
patent: 0 569 802 (1993-11-01), None
patent: 2421891 (1977-10-01), None
patent: 2000-80047 (2000-03-01), None
patent: 2000-256299 (2000-09-01), None
patent: 2001-517493 (2001-10-01), None
patent: 96112771 (1998-09-01), None
patent: WO-91/08205 (1991-06-01), None
patent: WO-91/08206 (1991-06-01), None
patent: WO-01/98267 (2001-12-01), None
patent: WO-02/13801 (2002-02-01), None
patent: WO-03/048113 (2003-06-01), None
patent: WO-2005/046687 (2005-05-01), None
Chang et al., Current Treatment Options in Gastroenterology, (2006), 9:314-323.
The Merck Manual, 17th edition (1999), pp. 312-313.
Barber et al., B. J. Pharmacol. (1994) 113:1317-1327.
Barber and Gottschlich, Expert Opin. Invest. Drugs (1997) 6(10):1351-1368.
Bardhan et al., Aliment Pharamacol. Ther. (2000) 14:23-34.
Binder et al., Anesthesiology (2001) 94:1034-1044.
Burton and Gebhart, J. Pharmacol. Exp. Ther. (1998) 285:707-715.
Camilleri et al., Arch. Intern. Med. (2001) 161(14):1733-1740.
Camilleri et al., Lancet (2000) 355(9209):1035-1040.
Coulie et al., Gastroenterology (2000) 119:41-50.
Dehaven-Hudkins et al., J. Pharmacol. Exp. Ther. (1999) 289(1):494-502.
Delvaux, Expert Opin. Investig. Drugs (2001) 10(1):97-110.
Endoh et al., Life Sci. (1999) 65(16):1685-1694.
Gottschlich et al., Chirality (1994) 6:685-689.
Hahn et al., Dig. Dis. Sci. (1998) 43:2715-2718.
Heaton et al., Gut (1991) 32(1):73-79.
Holtmann et al., Am J. Gastroenterol. (1997) 92:954-959.
International Search Report for PCT/US08/56317, mailed on Jun. 24, 2008, 2 pages.
Joshi et al., J. Neurosci. (2000) 20(15):5874-5879.
Longstreth et al., Gastroenterology (2006) 130(5):1480-1491.
Mayer and Gebhart, Basic and Clinical Aspects of Chronic Abdominal Pain, vol. 9, First Edition, Amsterdam: Elsevier, 1993, pp. 3-28.
Nemmani and Ramarao, Life Sci. (2002) 70(15):1727-1740.
Olden, Cleveland Clinic J. Med. (2003) 70(Suppl 2):S3-S7.
Patrick et al., Dig. Dis. Sci. (1998) 43:400-411.
Riviere et al., Acta. Neurobiol. Exp. (1999) 59:186.
Rogers et al., Br. J. Pharmacol. (1992) 106(4):783-789.
Sandner-Kiesling et al., Pain (2002) 96(1-2):13-22.
Schmidt, Am. J. Surg. (2001) 182(Suppl 5A):27S-38S.
Stachura and Herman, Pol. J. Pharmacol. (1994) 46(1-2):37-41.
Suzuki et al., Biol. Pharm. Bull. (1997) 20(11):1193-1198.
Trimble et al., Dig. Dis. Sci. (1995) 40:1607-1613.
Walsh et al., Psychopharmacology (2001) 157(2):151-162.
Written Opinion of the International Searching Authority for PCT/US08/56317, mailed on Jun. 24, 2008, 4 pages.
Yan and Roth, Life Sci. (2004) 75:2615-2619.
Zigmond and Snaith, Acta Psychiatr. Scand. (1983) 67(6):361-370.
Camilleri, Current Opinion in Pharmacology (2008) 8:671-676.
Camilleri et al., Gastroenterology (2008) 135:1877-1891.
Camilleri, Neurogastroenterol Motil (2008) 20:971-979.
Choung et al., Program of the Annual Meeting of the American Gastroenterlogical Association and Digestive Disease Week, May 19-24, 2007, AGA Abstracts, M1154, p. A-373.
Delgado-Aros et al., Current Treatment Options in Gastroenterology (2004) 7:121-131.
Delgado-Aros et al., Am. J. Physiol. Gastrointest. Liver Physiol. (2003) 284:G558-G566.
Delgado-Aros et al., Gastroenterology (2002) 122:A-59.
Mangel et al., Aliment Pharmacol Ther (2008) 28:239-249.
Mangel et al., Neurogastroenterol Motil (2008) 20:1086-1093.
Szarka et al., Clinical Gastroenterology and Hepatology (2007) 5:1268-1275.
Szarka et al., Program of the Annual Meeting of the American Gastroenterlogical Association and Digestive Disease Week, May 19-24, 2007, AGA Abstracts, W1213, p. A-684.
Talley et al., Aliment Pharmacol Ther (2008) 27:1122-1131.
Bhargava et al., Brain Research (1993) 625(1):120-124.
Boeckxstaens et al., The Am. J. of Gastroenterology (2002) 91:1.
CA78(9) 58099r, Clemence et al., FR 2113786 patent abstract Aug. 1972.
CA77(11) 75024, Clemence et al., DE 2155906 patent abstract May 1972.
Corazziari, Can. J. Gastroenterol. (1999) 13(Suppl A):71A-75A.
Encyclopedia of Medicaments M. RLS, 2001, pp. 583-585 and 1067-1068 (English Translation only).
Gevaerd et al., Braz. J. Med. Biol. Res. (1999) 32(12):1545-1550.
Glazer, Arch. Intern. Med. (2001) 161(15):1814-1824.
Gottschlich et al., Drugs Exptl. Clin. Res. (1995) XX(5):171-174.
Hasler, “Disorders of Gastric Emptying,” in: Textbook of Gastroenterology, 3rd edition, Yamada (ed.), Lippincott Williams & Wilkins, Philadelphia (1999) Ch. 63, pp. 1341-1369.
Hendrickson et al., Clin. Microbiology Reviews (2002) 79-94.
Hendrickson et al., Organic Chemistry 3rd. ed. (1970) p. 513.
Isselbacker et al., “Harrison's Principles of Internal Medicine” vol. 2, Thirteenth ed. (1994) pp. 1403-1417.
Jarosz et al., Biol. Res. Nurs. (2002) 3(4):198-209.
Johnson, Medical Hypotheses (1995) 45(5):491-497.
Mendelson, American Journal of Psychiatry (2001) 158(6):963-964.
Morley et al., American Journal of Clinical Nutrition (1985) 42(6):1175-1178.
Morley et al., Life Sciences (1982) 31:2617-2626.
Morley and Levine, Peptides (1983) 4:797-800.
Quigley, Expert Opinion on Pharmacotherapy (2000) 1:881-887.
Ramabadran, European Journal of Pharmacology (1984) 98(3-4):425-427.
Read et al., Gut (1997) 41:664-668.
Roger et al., Can. J. Vet. Res. (1994) 58(3):163-166.
Tarayre et al., Arzneim-Forsch./Drug Res. (1983) 33(II)7:931-935.
Tortella et al., Journal of Pharmacology and Experimental Therapeutics (1997) 282(1):286-293.
Upton et al., European Journal of Pharmacology (1982) 78(4):421-429.
Winter et al., “Effects of mu- and kappa-opiod receptors on postoperative ileus in rats”, Eur. J. Pharmacol. (1997) 339(1):63-67.
Delvaux et al., Aliment Pharmacol. Ther. (2004) 20:237-246.
Gottschlich et al., Bioorganic & Medicinal Chemistry Letters (1994) 4(5):677-682.
Office Action in EP 08731748.3, mailed Mar. 17, 2011, 4 pages.
Lemcke et al., European Journal of Pharmacology (1991) 193:109-115.
Shook et al., Journal of Pharmacology and Experimental Therapeutics (1989) 249:83-90.
Supplementary European Search Report for EP 08 73 1748, mailed on Apr. 27, 2010, 9 pages.
Morrison & Foerster / LLP
Spivack Phyllis G.
Tioga Pharmaceuticals, Inc
LandOfFree
Kappa-opiate agonists for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kappa-opiate agonists for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kappa-opiate agonists for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2712795